Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janset Onyuru

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|December 13, 2023
BRP39 Regulates Neutrophil Recruitment in NLRP3 Inflammasome-Induced Liver InflammationLin Kui, Andrea D Kim, Janset Onyuru, et al.
Nature Reviews. Endocrinology|October 17, 2025
Interleukin-18 in obesity and obesity-related metabolic diseasesChristian Stoess, Janset Onyuru, Phillipp Hartmann, et al.
Biomedicines|March 28, 2024
Cell Death in Liver Disease and Liver SurgeryChristian Stoess, Yeon-Kyung Choi, Janset Onyuru, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammationRoni Klein, Janset Onyuru, Estela M Viera, et al.
Nucleic Acids Research|November 8, 2025
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammationRoni Klein, Janset Onyuru, Jessica L Centa, et al.
Immunity|July 14, 2022
Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signalingHongxu Xian, Kosuke Watari, Elsa Sanchez-Lopez, et al.
Nature Immunology|June 17, 2025
Mitochondrial DNA oxidation propagates autoimmunity by enabling plasmacytoid dendritic cells to induce T<sub>FH</sub> differentiationHongxu Xian, Kosuke Watari, Masafumi Ohira, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950Angela Lackner, Lemuel Leonidas, Alijah Macapagal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2026
Myeloid ATF3 Protects Against Liver Fibrosis by Modulating the Extracellular Microenvironment and Macrophage Inflammatory SignalingHao Ling, Yanzhu Hu, Janset Onyuru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2023
Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 MiceBenedikt Kaufmann, Marta de Los Reyes Jiménez, Laela M Booshehri, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cellular and Molecular Gastroenterology and Hepatology|December 13, 2023
BRP39 Regulates Neutrophil Recruitment in NLRP3 Inflammasome-Induced Liver InflammationLin Kui, Andrea D Kim, Janset Onyuru, et al.
Nature Reviews. Endocrinology|October 17, 2025
Interleukin-18 in obesity and obesity-related metabolic diseasesChristian Stoess, Janset Onyuru, Phillipp Hartmann, et al.
Biomedicines|March 28, 2024
Cell Death in Liver Disease and Liver SurgeryChristian Stoess, Yeon-Kyung Choi, Janset Onyuru, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammationRoni Klein, Janset Onyuru, Estela M Viera, et al.
Nucleic Acids Research|November 8, 2025
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammationRoni Klein, Janset Onyuru, Jessica L Centa, et al.
Immunity|July 14, 2022
Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signalingHongxu Xian, Kosuke Watari, Elsa Sanchez-Lopez, et al.
Nature Immunology|June 17, 2025
Mitochondrial DNA oxidation propagates autoimmunity by enabling plasmacytoid dendritic cells to induce T<sub>FH</sub> differentiationHongxu Xian, Kosuke Watari, Masafumi Ohira, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950Angela Lackner, Lemuel Leonidas, Alijah Macapagal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2026
Myeloid ATF3 Protects Against Liver Fibrosis by Modulating the Extracellular Microenvironment and Macrophage Inflammatory SignalingHao Ling, Yanzhu Hu, Janset Onyuru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2023
Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 MiceBenedikt Kaufmann, Marta de Los Reyes Jiménez, Laela M Booshehri, et al.
Pageof 2